494 related articles for article (PubMed ID: 28384840)
1. Causal inference in survival analysis using pseudo-observations.
Andersen PK; Syriopoulou E; Parner ET
Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
[TBL] [Abstract][Full Text] [Related]
2. How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?
McNamee R
Stat Med; 2017 Sep; 36(21):3315-3333. PubMed ID: 28621000
[TBL] [Abstract][Full Text] [Related]
3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
4. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
[TBL] [Abstract][Full Text] [Related]
5. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
[TBL] [Abstract][Full Text] [Related]
6. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
[TBL] [Abstract][Full Text] [Related]
7. Fast approximations of pseudo-observations in the context of right censoring and interval censoring.
Bouaziz O
Biom J; 2023 Apr; 65(4):e2200071. PubMed ID: 36843309
[TBL] [Abstract][Full Text] [Related]
8. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
9. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
Nie H; Cheng J; Small DS
Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
[TBL] [Abstract][Full Text] [Related]
10. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
Savani BN; Labopin M; Kröger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socié G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Jun; 101(6):773-80. PubMed ID: 26969081
[TBL] [Abstract][Full Text] [Related]
11. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
Waernbaum I
Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
[TBL] [Abstract][Full Text] [Related]
12. G-estimation of structural nested mean models for competing risks data using pseudo-observations.
Tanaka S; Brookhart MA; Fine JP
Biostatistics; 2020 Oct; 21(4):860-875. PubMed ID: 31056651
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
[TBL] [Abstract][Full Text] [Related]
14. An inverse probability weighted regression method that accounts for right-censoring for causal inference with multiple treatments and a binary outcome.
Yu Y; Zhang M; Mukherjee B
Stat Med; 2023 Sep; 42(20):3699-3715. PubMed ID: 37392070
[TBL] [Abstract][Full Text] [Related]
15. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
16. A connection between survival multistate models and causal inference for external treatment interruptions.
Erdmann A; Loos A; Beyersmann J
Stat Methods Med Res; 2023 Feb; 32(2):267-286. PubMed ID: 36464917
[TBL] [Abstract][Full Text] [Related]
17. Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.
Cho Y; Hu C; Ghosh D
Stat Med; 2018 Feb; 37(3):390-404. PubMed ID: 29023972
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
19. Simulating survival data with predefined censoring rates for proportional hazards models.
Wan F
Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
[TBL] [Abstract][Full Text] [Related]
20. Impact of censoring on learning Bayesian networks in survival modelling.
Stajduhar I; Dalbelo-Basić B; Bogunović N
Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
